Mohammad Azab and Pietro Taverna - Free people check

(1 - 6 from 7

)

Epigenetics meets immune checkpoints - PubMed

pubmed.ncbi.nlm.nih.gov

by A Covre · · Cited by 29 — Authors. Alessia Covre , Sandra Coral , Anna Maria Di Giacomo , Pietro Taverna , Mohammad Azab , Michele Maio. Affiliations. › ...

All web results to the name "Mohammad Azab"

Amuvatinib (MP-470, HPK 56)|Tyrosine kinase inhibitor|CAS#

www.apexbt.com

Raoul Tibes, Gil Fine, Gavin Choy, Sanjeev Redkar, Pietro Taverna, Aram Oganesian, Amarpao Sahai, Mohammad Azab and Anthony W. Tolcher. A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors. Cancer Chemother Pharmacol ...

A phase I, first-in-human dose-escalation study of amuvatinib, a...

mayoclinic.pure.elsevier.com

Raoul Tibes, Gil Fine, Gavin Choy, Sanjeev Redkar, Pietro Taverna, Aram Oganesian, Amarpal Sahai, Mohammad Azab, Anthony W. Tolcher. Hematology/ ...

The novel, small-molecule DNA methylation inhibitor SGI

www.scholars.northwestern.edu

by F Fang · · Cited by 99 — Fang Fang, Joanne Munck, Jessica Tang, Pietro Taverna, Yinu Wang, David F B Miller, Jay Pilrose, Gavin Choy, Mohammad Azab, Katherine S. › publications